Once daily ledipasvir/sofosbuvir fixed-dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection
Author:
Affiliation:
1. Gastroenterology Department; Christchurch Hospital and University of Otago; Christchurch New Zealand
2. Gilead Sciences Inc.; Foster City CA United States
3. New Zealand Liver Transplant Unit; Auckland City Hospital; Auckland New Zealand
Funder
Gilead Sciences
Publisher
Wiley
Subject
Genetics(clinical),Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12791/fullpdf
Reference9 articles.
1. New approaches to the management of hepatitis C in haemophilia in 2012;Zoulim;Haemophilia,2012
2. Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders;Fransen van de Putte;J Hepatol,2014
3. Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis;Franchini;J Antimicrob Chemother,2008
4. Harvoni (ledipasvir and sofosbuvir) tablets: US prescribing information Foster City, CA Gilead Sciences http://www.gilead.com/~/media/Files/pdfs/medicines/liverdisease/harvoni/harvoni_pi.pdf
5. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N Engl J Med,2014
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease;Egyptian Liver Journal;2024-09-09
2. Liver‐related complications before and after successful treatment of chronic hepatitis C virus infection in people with inherited bleeding disorders;Haemophilia;2022-10-02
3. Hepatitis C Virus Infections in Patients with Hemophilia: Links, Risks and Management;Journal of Multidisciplinary Healthcare;2022-10
4. Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders;Turkish Journal of Gastroenterology;2022-05-26
5. Clinical burden of hemophilia in older adults: Beyond bleeding risk;Blood Reviews;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3